Raymond James Financial Services Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$584K	Buy
2024 Q2	$318K	Buy
2024 Q1	–	Sell
2023 Q4	$1.08M	Sell
2023 Q3	$1.54M	Sell
2023 Q2	$1.37M	Buy
2023 Q1	$1.46M	Buy
2022 Q4	$1.62M	Buy
2022 Q3	$486K	Buy
2018 Q4	–	Sell
2018 Q3	$236K	Buy